Exact Sciences
EXAS
#1179
Rank
NZ$32.27 B
Marketcap
NZ$169.93
Share price
0.04%
Change (1 day)
70.94%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): NZ-$9.42

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is NZ-$8.83. In 2024 the company made an earnings per share (EPS) of NZ-$9.25.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$9.421.87%
2024NZ-$9.25
2022NZ-$5.882.31%
2021NZ-$5.74-38.54%
2020NZ-$9.35692.96%
2019NZ-$1.18-50.69%
2018NZ-$2.3944%
2017NZ-$1.66-39.39%
2016NZ-$2.74-2.94%
2015NZ-$2.8237.1%
2014NZ-$2.0679.71%
2013NZ-$1.15-21.59%
2012NZ-$1.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$6.15-169.66%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
NZ$0.65-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.56-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.19-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ-$84.51 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA